ID   FA92A_HUMAN             Reviewed;         289 AA.
AC   A1XBS5; A1XBS4; Q32ND3; Q6AHW7; Q8N8R1; Q96L09;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 2.
DT   07-APR-2021, entry version 107.
DE   RecName: Full=Protein FAM92A;
GN   Name=FAM92A {ECO:0000312|HGNC:HGNC:30452}; Synonyms=FAM92A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND SUBCELLULAR LOCATION
RP   (ISOFORM 3).
RX   PubMed=17646714;
RA   Ruan X.Z., Yan F., Zhao X.Y., Wang C.T., Song M., Yang H.S., Deng H.X.,
RA   Wei Y.Q.;
RT   "Identification and characterization of two novel variants of the DUF1208
RT   protein FAM92A1.";
RL   Mol. Cells 23:391-397(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH CBY1, SUBCELLULAR LOCATION, FUNCTION, SUBUNIT, AND
RP   MUTAGENESIS OF LYS-107; ARG-110; LYS-114; ARG-132; ARG-134 AND ARG-136.
RX   PubMed=27528616; DOI=10.1128/mcb.00160-16;
RA   Li F.Q., Chen X., Fisher C., Siller S.S., Zelikman K., Kuriyama R.,
RA   Takemaru K.I.;
RT   "BAR domain-containing FAM92 proteins interact with chibby1 to facilitate
RT   ciliogenesis.";
RL   Mol. Cell. Biol. 36:2668-2680(2016).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH CBY1, SUBUNIT, INVOLVEMENT
RP   IN PAPA9, VARIANT PAPA9 160-ARG--LYS-289 DEL, AND CHARACTERIZATION OF
RP   VARIANT PAPA9 160-ARG--LYS-289 DEL.
RX   PubMed=30395363; DOI=10.1002/jbmr.3594;
RA   Schrauwen I., Giese A.P., Aziz A., Lafont D.T., Chakchouk I.,
RA   Santos-Cortez R.L.P., Lee K., Acharya A., Khan F.S., Ullah A.,
RA   Nickerson D.A., Bamshad M.J., Ali G., Riazuddin S., Ansar M., Ahmad W.,
RA   Ahmed Z.M., Leal S.M.;
RT   "FAM92A underlies nonsyndromic postaxial polydactyly in humans and an
RT   abnormal limb and digit skeletal phenotype in mice.";
RL   J. Bone Miner. Res. 34:375-386(2019).
CC   -!- FUNCTION: Acts as a positive regulator of ciliary hedgehog signaling
CC       (By similarity). Probable regulator of ciliogenesis involved in limb
CC       morphogenesis. In cooperation with CBY1 it is involved in the
CC       recruitment and fusion of endosomal vesicles at distal appendages
CC       during early stages of ciliogenesis. {ECO:0000250|UniProtKB:Q8BP22,
CC       ECO:0000269|PubMed:27528616, ECO:0000269|PubMed:30395363}.
CC   -!- SUBUNIT: Homodimer (via BAR-like domain) (PubMed:27528616,
CC       PubMed:30395363). Heterodimer with FAM92B (via BAR-like domains)
CC       (PubMed:27528616). Interacts (via BAR-like domain) with CBY1; this
CC       interaction is required for targeting FAM92A to centriole and cilium
CC       basal body (PubMed:27528616, PubMed:30395363).
CC       {ECO:0000269|PubMed:27528616, ECO:0000269|PubMed:30395363}.
CC   -!- INTERACTION:
CC       A1XBS5; Q9Y3M2: CBY1; NbExp=3; IntAct=EBI-2349888, EBI-947308;
CC       A1XBS5-3; Q9Y3M2: CBY1; NbExp=3; IntAct=EBI-12348777, EBI-947308;
CC       A1XBS5-3; Q8NA61-2: CBY2; NbExp=3; IntAct=EBI-12348777, EBI-11524851;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:27528616}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome,
CC       centriole {ECO:0000269|PubMed:27528616}. Cytoplasm, cytoskeleton,
CC       cilium basal body {ECO:0000269|PubMed:27528616,
CC       ECO:0000269|PubMed:30395363}. Cell projection, cilium
CC       {ECO:0000250|UniProtKB:Q8BP22}. Note=Weak punctate vesicular
CC       distribution throughout the cytoplasm (PubMed:27528616). Localizes at
CC       the distal end of mother centrioles (PubMed:27528616). Extensive
CC       colocalization with CBY1 at mother centrioles (PubMed:27528616).
CC       {ECO:0000269|PubMed:27528616}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Nucleus
CC       {ECO:0000269|PubMed:17646714}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=FAM92A1-289 {ECO:0000303|PubMed:17646714};
CC         IsoId=A1XBS5-1; Sequence=Displayed;
CC       Name=2; Synonyms=FAM92A1-251 {ECO:0000303|PubMed:17646714};
CC         IsoId=A1XBS5-2; Sequence=VSP_025294;
CC       Name=3;
CC         IsoId=A1XBS5-3; Sequence=VSP_025296;
CC       Name=4;
CC         IsoId=A1XBS5-4; Sequence=VSP_025295;
CC       Name=5;
CC         IsoId=A1XBS5-5; Sequence=VSP_025292, VSP_025293;
CC   -!- DOMAIN: The BAR-like domain displays limited similarity to other BAR
CC       domains. {ECO:0000305|PubMed:27528616}.
CC   -!- DISEASE: Polydactyly, postaxial, A9 (PAPA9) [MIM:618219]: A form of
CC       postaxial polydactyly, a condition characterized by the occurrence of
CC       supernumerary digits in the upper and/or lower extremities. In
CC       postaxial polydactyly type A, the extra digit is well-formed and
CC       articulates with the fifth or a sixth metacarpal/metatarsal. PAPA9 is
CC       an autosomal recessive condition characterized by one or more posterior
CC       or postaxial digits. {ECO:0000269|PubMed:30395363}. Note=The disease
CC       may be caused by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the FAM92 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH14598.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAI08708.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ327715; ABC55436.1; -; mRNA.
DR   EMBL; DQ327716; ABC55437.1; -; mRNA.
DR   EMBL; AK096298; BAC04753.1; -; mRNA.
DR   EMBL; CR627475; CAH10675.1; -; mRNA.
DR   EMBL; AC010834; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC120053; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC014598; AAH14598.2; ALT_INIT; mRNA.
DR   EMBL; BC108707; AAI08708.1; ALT_INIT; mRNA.
DR   CCDS; CCDS47892.1; -. [A1XBS5-1]
DR   CCDS; CCDS64933.1; -. [A1XBS5-2]
DR   RefSeq; NP_001269963.1; NM_001283034.1. [A1XBS5-2]
DR   RefSeq; NP_660312.2; NM_145269.4. [A1XBS5-1]
DR   SMR; A1XBS5; -.
DR   BioGRID; 126476; 10.
DR   IntAct; A1XBS5; 6.
DR   STRING; 9606.ENSP00000429367; -.
DR   iPTMnet; A1XBS5; -.
DR   PhosphoSitePlus; A1XBS5; -.
DR   BioMuta; FAM92A; -.
DR   EPD; A1XBS5; -.
DR   jPOST; A1XBS5; -.
DR   MassIVE; A1XBS5; -.
DR   MaxQB; A1XBS5; -.
DR   PaxDb; A1XBS5; -.
DR   PeptideAtlas; A1XBS5; -.
DR   PRIDE; A1XBS5; -.
DR   ProteomicsDB; 157; -. [A1XBS5-1]
DR   ProteomicsDB; 158; -. [A1XBS5-2]
DR   ProteomicsDB; 159; -. [A1XBS5-3]
DR   ProteomicsDB; 160; -. [A1XBS5-4]
DR   ProteomicsDB; 161; -. [A1XBS5-5]
DR   Antibodypedia; 25708; 120 antibodies.
DR   DNASU; 137392; -.
DR   Ensembl; ENST00000423990; ENSP00000401774; ENSG00000188343. [A1XBS5-2]
DR   Ensembl; ENST00000452913; ENSP00000391671; ENSG00000188343. [A1XBS5-3]
DR   Ensembl; ENST00000518116; ENSP00000428065; ENSG00000188343. [A1XBS5-4]
DR   Ensembl; ENST00000518322; ENSP00000429367; ENSG00000188343. [A1XBS5-1]
DR   GeneID; 137392; -.
DR   KEGG; hsa:137392; -.
DR   UCSC; uc064onr.1; human. [A1XBS5-1]
DR   CTD; 137392; -.
DR   DisGeNET; 137392; -.
DR   GeneCards; CIBAR1; -.
DR   HGNC; HGNC:30452; FAM92A.
DR   HPA; ENSG00000188343; Tissue enhanced (testis).
DR   MalaCards; CIBAR1; -.
DR   MIM; 617273; gene.
DR   MIM; 618219; phenotype.
DR   neXtProt; NX_A1XBS5; -.
DR   OpenTargets; ENSG00000188343; -.
DR   Orphanet; 93334; Postaxial polydactyly type A.
DR   PharmGKB; PA142671823; -.
DR   VEuPathDB; HostDB:ENSG00000188343.12; -.
DR   eggNOG; ENOG502QQ0N; Eukaryota.
DR   GeneTree; ENSGT00390000010285; -.
DR   HOGENOM; CLU_072172_1_0_1; -.
DR   InParanoid; A1XBS5; -.
DR   OMA; FILISMK; -.
DR   OrthoDB; 1324464at2759; -.
DR   PhylomeDB; A1XBS5; -.
DR   TreeFam; TF324316; -.
DR   PathwayCommons; A1XBS5; -.
DR   BioGRID-ORCS; 137392; 5 hits in 959 CRISPR screens.
DR   ChiTaRS; FAM92A; human.
DR   GenomeRNAi; 137392; -.
DR   Pharos; A1XBS5; Tbio.
DR   PRO; PR:A1XBS5; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; A1XBS5; protein.
DR   Bgee; ENSG00000188343; Expressed in testis and 198 other tissues.
DR   ExpressionAtlas; A1XBS5; baseline and differential.
DR   Genevisible; A1XBS5; HS.
DR   GO; GO:0005814; C:centriole; IDA:UniProtKB.
DR   GO; GO:0036064; C:ciliary basal body; IEA:Ensembl.
DR   GO; GO:0097546; C:ciliary base; IDA:UniProtKB.
DR   GO; GO:0035869; C:ciliary transition zone; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005543; F:phospholipid binding; IDA:UniProtKB.
DR   GO; GO:0060271; P:cilium assembly; IMP:UniProtKB.
DR   GO; GO:0007007; P:inner mitochondrial membrane organization; IMP:UniProtKB.
DR   GO; GO:0035108; P:limb morphogenesis; IMP:UniProtKB.
DR   GO; GO:0061024; P:membrane organization; IDA:UniProtKB.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; ISS:UniProtKB.
DR   CDD; cd07598; BAR_FAM92; 1.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR035590; BAR_FAM92.
DR   InterPro; IPR009602; FAM92.
DR   PANTHER; PTHR21223; PTHR21223; 1.
DR   Pfam; PF06730; FAM92; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell projection; Cilium biogenesis/degradation;
KW   Coiled coil; Cytoplasm; Cytoskeleton; Disease variant; Nucleus;
KW   Reference proteome.
FT   CHAIN           1..289
FT                   /note="Protein FAM92A"
FT                   /id="PRO_0000287080"
FT   REGION          10..220
FT                   /note="BAR-like"
FT                   /evidence="ECO:0000305|PubMed:27528616"
FT   COILED          107..178
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         89..97
FT                   /note="ERLEAKVVE -> WSEITVSLL (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_025292"
FT   VAR_SEQ         98..289
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_025293"
FT   VAR_SEQ         182..219
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17646714"
FT                   /id="VSP_025294"
FT   VAR_SEQ         220..289
FT                   /note="VFRNSLYAPDYSSRLDIVRANSKSPLQRSLSAKCVSGTGQVSTCRLRKDQQA
FT                   EDDEDDELDVTEEENFLK -> RWSFAMLPRLVLNSWGSSDPPALASQSVRFSEILCMH
FT                   QIIHLV (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_025295"
FT   VAR_SEQ         260..289
FT                   /note="VSTCRLRKDQQAEDDEDDELDVTEEENFLK -> EAGWAATCQTLI (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_025296"
FT   VARIANT         160..289
FT                   /note="Missing (in PAPA9; does not form homodimers; does
FT                   not interact with CBY1; does not localize to cilium basal
FT                   body)"
FT                   /evidence="ECO:0000269|PubMed:30395363"
FT                   /id="VAR_081578"
FT   VARIANT         222
FT                   /note="R -> Q (in dbSNP:rs36117362)"
FT                   /id="VAR_062190"
FT   MUTAGEN         107
FT                   /note="K->E: Abolishes ability to induce membrane
FT                   remodeling in the presence of CBY1; when associated with E-
FT                   110; E-114; E-132; E-134 and E-136."
FT                   /evidence="ECO:0000269|PubMed:27528616"
FT   MUTAGEN         110
FT                   /note="R->E: Abolishes ability to induce membrane
FT                   remodeling in the presence of CBY1; when associated with E-
FT                   107;E-114; E-132; E-134 and E-136."
FT                   /evidence="ECO:0000269|PubMed:27528616"
FT   MUTAGEN         114
FT                   /note="K->E: Abolishes ability to induce membrane
FT                   remodeling in the presence of CBY1; when associated with E-
FT                   107; E-110; E-132; E-134 and E-136."
FT                   /evidence="ECO:0000269|PubMed:27528616"
FT   MUTAGEN         132
FT                   /note="R->E: Abolishes ability to induce membrane
FT                   remodeling in the presence of CBY1; when associated with E-
FT                   107; E-110; E-114; E-134 and E-136."
FT                   /evidence="ECO:0000269|PubMed:27528616"
FT   MUTAGEN         134
FT                   /note="R->E: Abolishes ability to induce membrane
FT                   remodeling in the presence of CBY1; when associated with E-
FT                   107; E-110; E-114; E-132 and E-136."
FT                   /evidence="ECO:0000269|PubMed:27528616"
FT   MUTAGEN         136
FT                   /note="R->E: Abolishes ability to induce membrane
FT                   remodeling in the presence of CBY1; when associated with E-
FT                   107; E-110; E-114; E-132 and E-134."
FT                   /evidence="ECO:0000269|PubMed:27528616"
FT   CONFLICT        137
FT                   /note="N -> S (in Ref. 1; ABC55436)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        150
FT                   /note="E -> G (in Ref. 2; BAC04753)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        281
FT                   /note="V -> I (in Ref. 1; ABC55437)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   289 AA;  33431 MW;  CC95F1A4217FDCA5 CRC64;
     MMRRTLENRN AQTKQLQTAV SNVEKHFGEL CQIFAAYVRK TARLRDKADL LVNEINAYAA
     TETPHLKLGL MNFADEFAKL QDYRQAEVER LEAKVVEPLK TYGTIVKMKR DDLKATLTAR
     NREAKQLTQL ERTRQRNPSD RHVISQAETE LQRAAMDASR TSRHLEETIN NFERQKMKDI
     KTIFSEFITI EMLFHGKALE VYTAAYQNIQ NIDEDEDLEV FRNSLYAPDY SSRLDIVRAN
     SKSPLQRSLS AKCVSGTGQV STCRLRKDQQ AEDDEDDELD VTEEENFLK
//
